Transcat FY2029 EPS Forecast Cut by Northland Securities

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Securities reduced their FY2029 EPS estimates for shares of Transcat in a research note issued to investors on Wednesday, February 4th. Northland Securities analyst E. Jackson now anticipates that the scientific and technical instruments company will earn $2.89 per share for the year, down from their previous estimate of $2.96. Northland Securities has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Securities also issued estimates for Transcat’s FY2030 earnings at $3.18 EPS.

Other equities analysts also recently issued reports about the company. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research report on Monday, December 29th. Zacks Research lowered shares of Transcat from a “hold” rating to a “strong sell” rating in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $105.33.

Transcat Stock Up 8.4%

Shares of TRNS opened at $76.33 on Friday. The stock’s 50-day moving average price is $60.23 and its two-hundred day moving average price is $68.44. Transcat has a 12 month low of $50.23 and a 12 month high of $97.08. The company has a market capitalization of $712.16 million, a PE ratio of 89.80 and a beta of 0.79. The company has a current ratio of 2.21, a quick ratio of 2.06 and a debt-to-equity ratio of 0.34.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.04). The business had revenue of $83.86 million during the quarter, compared to the consensus estimate of $80.99 million. Transcat had a return on equity of 6.15% and a net margin of 2.47%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. State of Alaska Department of Revenue bought a new position in shares of Transcat in the third quarter valued at $40,000. Lazard Asset Management LLC bought a new position in Transcat in the 2nd quarter valued at about $54,000. Parkside Financial Bank & Trust bought a new position in Transcat in the 2nd quarter valued at about $79,000. PNC Financial Services Group Inc. boosted its stake in Transcat by 1,118.2% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock valued at $92,000 after purchasing an additional 984 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in Transcat by 245.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after purchasing an additional 798 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Key Stories Impacting Transcat

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Northland raised near‑term estimates: Q4 2026 EPS was bumped to $0.55 (from $0.46), and FY2026 EPS was raised to $1.83 (from $1.75). These upgrades support stronger near‑term earnings expectations and likely helped lift the stock.
• Positive Sentiment: Northland also increased FY2027 and FY2028 EPS forecasts to $1.86 (from $1.70) and $2.15 (from $2.07), respectively — further evidence the firm sees improving performance over the next couple of years.
• Neutral Sentiment: Northland retains a “Strong‑Buy” rating and continues to publish multi‑year projections (FY2026–FY2030), which provides a bullish anchor for some institutional investors but also creates mixed signals because revisions vary by year.
• Negative Sentiment: Northland trimmed longer‑range estimates: FY2029 EPS was lowered to $2.89 (from $2.96) and FY2030 EPS to $3.18 (from $3.51). Those cuts suggest tempered longer‑term growth assumptions and may limit how far momentum can run.
• Negative Sentiment: Zacks Research downgraded TRNS from “Hold” to “Strong Sell,” adding a negative analyst voice that can pressure sentiment, especially among retail investors. Read more: Zacks.com TickerReport

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.